Return
SARM1-Dependent Antimetabolic Cancer Therapy
A
D
A
L
J
S
F
G
T
B
L
A
DOI:10.1016/j.canlet.2026.218762.png)
Abstract
En 中文
• Transduction of active SARM1 NADase prompts bioenergetic failure in cancer cells. • Tumor xenografts undergo rapid regression when prompted to express active SARM1. • Data disclose the anticancer potential of SARM1 gene therapy.
Keywords:
SARM1
NAD metabolism
cancer
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
10.1
Papers:
1.7W
Citations:
4.3W
